Q: I own a fair bit of PHM, mentioned in a past comment, bought at 15 cents.
I noticed today that the debenture below just hit 52wh.
Patient Home Monitoring
PHM.DB-X
85.00 / 57.50
Question: if I want to add to my position, would the debenture be a better option or should I stick simply to the stock.
Thanks,
CDJ
Q: I have an average price on BMY shares of $69 having bought near peak price...when the recommendations by other analysts ( not 5i) were extremely positive. After, the company missed expectations with a drug and the downfall began. Now, I am wondering, what factors would you consider in making the decision whether to exit this losing trade and put the $$ into an alternate pharm company such as GUD or an ETF such as some you have recently mentioned IHI.
Q: I have purchased 2500 shares of PLI over the year at varying prices from 2.40 to 1.60. At 1.50 today would this be a good opportunity to average down and buy more. Your opinion is much appreciated.
Q: CIBC has issued a downgrade on PLI reducing their target price from $4.40 to $2.15. I don not usually pay any attention to target prices but this seems to be a significant cut. They also mention cash burn rate and that the company will likely need additional financing.
Would appreciate your views on this. Thanks John
Q: I would like to invest n the US healthcare and have been recommended to invest in TMO but since this Would be the only stock in the healthcare that I would invest in I think it might be better to invest in a healthcare ETF and have found IXJ and IHI and wonder if better to invest in an ETF or ok just to invest in one US healthcare stock? If an ETF which one would you prefer?
Q: Little movement with GSK of late. Would you transfer out of this stock into another healthcare stock or is health care too out of favour and should move out of sector entirely for now. If out of favour, would you suggest another global stock?
Thanks. Lorraine
Q: James Davidson of Strategic Investment mentioned Polarityte Inc symbol COOL at $ 15.00 on May 22nd. It is now at $ 29.00 Company is involved with Stem Cells and Regenerate Limbs. Some interesting research has been done. Take a look . Could have huge potential RAK
Q: Hi Peter, Ryan, and 5i Team
I have had one eye on this company's stock price for a while. Are there any qualities that would make this company worthy of an investment?